EMPIRI INC.
Dave Gallup is a seasoned professional with extensive experience in the fields of engineering and business management. As the Co-founder and Chief Executive Officer of EMPIRICANCER since August 2018, Dave has demonstrated leadership and innovative thinking. Prior to this role, Dave served as a Business Advisor and General Manager at Eurofins from June 2014, and held various positions, including Consultant & Strategic Advisor at Eurofins TestAmerica from August 2002 to May 2014. Dave was the Owner and CEO of EMLab from August 1997 to July 2002, and served as Director of Operations at Amerigon from June 1993 to July 1997, where the management of an operational team was crucial for the production of components for electric vehicles and climate-controlled seats. Earlier in Dave's career, a progression of roles at TRW Technar Inc provided foundational engineering experience. Educational credentials include a Master of Science in Mechanical Design from Stanford University and a Bachelor of Science in Engineering & Applied Science from Caltech.
This person is not in any teams
EMPIRI INC.
A startup biotechnology platform company currently focused on precision oncology. EMPIRI is revolutionizing the way we treat cancer by providing empirical, personalized drug response data before treatments are selected for each patient by oncologists. We are building LDTs for specific cancer indications and a first-in-class automated cancer diagnostic instrument to scale our assays. We are also a 10x Genomic Certified Service Provider for single-cell analysis for clinical and preclinical studies.